Estimating efficacy in trials with selective crossover
From MaRDI portal
Cites work
- Adjusting for Differential Rates of Prophylaxis Therapy for PCP in High-Versus Low-Dose AZT Treatment Arms in an AIDS Randomized Trial
- Causal inference through potential outcomes and principal stratification: application to studies with ``censoring due to death
- Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests
- Estimating the Effect of Treatment in a Proportional Hazards Model in the Presence of Non-Compliance and Contamination
- Maximum Likelihood Estimation in Semiparametric Regression Models with Censored Data
- Principal stratification in causal inference
This page was built for publication: Estimating efficacy in trials with selective crossover
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6997477)